Showing results (621-630 of 911) with videos related to

Sort By:
Pageof 92
The Lancet. Psychiatry|January 17, 2026
Dose-dependent pharmacological mechanisms within the Neuroscience-based Nomenclature: a new concept to facilitate neuroscience-based prescribingSasson Zemach, Joseph Zohar, Christoph U Correll, et al.
The Lancet. Psychiatry|January 15, 2026
Delusion as embodied emotion: a qualitatively driven, multimethod study of first-episode psychosis in the UKRosa Ritunnano, Jeannette Littlemore, Barnaby Nelson, et al.
The Lancet. Psychiatry|December 18, 2025
Specific midlife depressive symptoms and long-term dementia risk: a 23-year UK prospective cohort studyPhilipp Frank, Archana Singh-Manoux, Jaana Pentti, et al.
The Lancet. Psychiatry|July 5, 2025
Absolute neutrophil count and adverse drug reaction monitoring during clozapine treatment: consensus guidelines from a global Delphi panelDan Siskind, Korinne Northwood, Toby Pillinger, et al.
The Lancet. Psychiatry|July 3, 2025
Non-suicidal self-injury: proposal to shift designation from disorder to a clinical specifierGregory J Lengel, Jennifer J Muehlenkamp, Maria Zetterqvist, et al.
The Lancet. Psychiatry|September 18, 2025
Mortality from respiratory diseases in individuals with severe mental illness: a large-scale systematic review and meta-analysis of pooled and specific diagnosesDavid Laguna-Muñoz, María P Pata, Ana Jiménez-Peinado, et al.
The Lancet. Psychiatry|September 19, 2025
Programmes for people who are homeless and have severe mental illness in low-income and middle-income countries: a systematic reviewLauren McPhail, Caroline Smartt, Christine Musyimi, et al.
The Lancet. Psychiatry|July 31, 2025
Clozapine use and risk of infections in patients with schizophrenia in Hong Kong: a population-based cohort studyYuqi Hu, Wenxin Tian, Cuiling Wei, et al.
The Lancet. Psychiatry|May 9, 2025
Recovery-oriented psychiatry: oxymoron or catalyst for change?Helene Speyer, David Roe, Mike Slade
The Lancet. Psychiatry|October 3, 2025
Disease relapse, all-cause mortality, and adverse events associated with long-acting injectable antipsychotics versus oral antipsychotics in older people with schizophrenia in Hong Kong: a population-based within-subject analysisYue Wei, Vincent K C Yan, David J Castle, et al.
Pageof 92